These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 9727878)

  • 1. Influence of timing on the dosimetric analysis of transperineal ultrasound-guided, prostatic conformal brachytherapy.
    Merrick GS; Butler WM; Dorsey AT; Walbert HL
    Radiat Oncol Investig; 1998; 6(4):182-90. PubMed ID: 9727878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of prostate size and isotope selection on dosimetric quality following permanent seed implantation.
    Merrick GS; Butler WM; Dorsey AT; Lief JH
    Tech Urol; 2001 Sep; 7(3):233-40. PubMed ID: 11575521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential role of various dosimetric quality indicators in prostate brachytherapy.
    Merrick GS; Butler WM; Dorsey AT; Lief JH
    Int J Radiat Oncol Biol Phys; 1999 Jun; 44(3):717-24. PubMed ID: 10348304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Timing of computed tomography-based postimplant assessment following permanent transperineal prostate brachytherapy.
    Prestidge BR; Bice WS; Kiefer EJ; Prete JJ
    Int J Radiat Oncol Biol Phys; 1998 Mar; 40(5):1111-5. PubMed ID: 9539566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostatic conformal brachytherapy: 125I/103Pd postoperative dosimetric analysis.
    Merrick GS; Butler WM; Dorsey AT; Walbert HL
    Radiat Oncol Investig; 1997; 5(6):305-13. PubMed ID: 9436248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A dynamic model for the estimation of optimum timing of computed tomography scan for dose evaluation of 125I or 103Pd seed implant of prostate.
    Yue N; Dicker AP; Corn BW; Nath R; Waterman FM
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):447-54. PubMed ID: 10030274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isotope choice and the effect of edema on prostate brachytherapy dosimetry.
    Butler WM; Merrick GS; Dorsey AT; Lief JH
    Med Phys; 2000 May; 27(5):1067-75. PubMed ID: 10841411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate seed implantation using 3D-computer assisted intraoperative planning vs. a standard look-up nomogram: Improved target conformality with reduction in urethral and rectal wall dose.
    Raben A; Chen H; Grebler A; Geltzeiler J; Geltzeiler M; Keselman I; Litvin S; Sim S; Hanlon A; Yang J
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1631-8. PubMed ID: 15590195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimum timing for image-based dose evaluation of 125I and 103PD prostate seed implants.
    Yue N; Chen Z; Peschel R; Dicker AP; Waterman FM; Nath R
    Int J Radiat Oncol Biol Phys; 1999 Nov; 45(4):1063-72. PubMed ID: 10571216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rectal dosimetric analysis following prostate brachytherapy.
    Merrick GS; Butler WM; Dorsey AT; Lief JH; Walbert HL; Blatt HJ
    Int J Radiat Oncol Biol Phys; 1999 Mar; 43(5):1021-7. PubMed ID: 10192350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brachytherapy in patients with small prostate glands.
    Loblaw DA; Wallner K; Dibiase S; Russell K; Blasko J; Ellis W
    Tech Urol; 2000 Jun; 6(2):64-9. PubMed ID: 10798802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postimplantation dosimetric analysis of permanent transperineal prostate implantation: improved dose distributions with an intraoperative computer-optimized conformal planning technique.
    Zelefsky MJ; Yamada Y; Cohen G; Venkatraman ES; Fung AY; Furhang E; Silvern D; Zaider M
    Int J Radiat Oncol Biol Phys; 2000 Sep; 48(2):601-8. PubMed ID: 10974481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of edema on planning 125I and 103Pd prostate implants.
    Yue N; Dicker AP; Nath R; Waterman FM
    Med Phys; 1999 May; 26(5):763-7. PubMed ID: 10360539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morbidity effect of the time gap between supplemental beam radiation and Pd-103 prostate brachytherapy.
    Corriveau J; Wallner K; Merrick G; True L; Cavanagh W; Sutlief S; Butler W
    Brachytherapy; 2003; 2(2):108-13. PubMed ID: 15062149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of real-time intraoperative ultrasound-based dosimetry with postoperative computed tomography-based dosimetry for prostate brachytherapy.
    Nag S; Shi P; Liu B; Gupta N; Bahnson RR; Wang JZ
    Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):311-7. PubMed ID: 17996395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of intraoperative dosimetric implant representation with postimplant dosimetry in patients receiving prostate brachytherapy.
    Stone NN; Hong S; Lo YC; Howard V; Stock RG
    Brachytherapy; 2003; 2(1):17-25. PubMed ID: 15062159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraoperative fluoroscopic dose assessment in prostate brachytherapy patients.
    Reed DR; Wallner KE; Narayanan S; Sutlief SG; Ford EC; Cho PS
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):301-7. PubMed ID: 16111600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dosimetry of prostate brachytherapy-induced urethral strictures.
    Merrick GS; Butler WM; Tollenaar BG; Galbreath RW; Lief JH
    Int J Radiat Oncol Biol Phys; 2002 Feb; 52(2):461-8. PubMed ID: 11872293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraoperative conformal optimization for transperineal prostate implantation using magnetic resonance spectroscopic imaging.
    Zelefsky MJ; Cohen G; Zakian KL; Dyke J; Koutcher JA; Hricak H; Schwartz L; Zaider M
    Cancer J; 2000; 6(4):249-55. PubMed ID: 11038145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seed fixity in the prostate/periprostatic region following brachytherapy.
    Merrick GS; Butler WM; Dorsey AT; Lief JH; Benson ML
    Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):215-20. PubMed ID: 10656395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.